Cytokine Signalling Forum

Publications





October 20

Eficácia de Baricitinib no Tratamento de Artrite Reumatoide: Efeito Modulatório em Biomarcadores Inflamatórios e de Fibrose em Circunstâncias de Vida Real

Alessandro M, Perillo F, Refini R, Bergantini L, Bellisai F, Selvi E, Cameli P, Manganelli S, Conticini E, Cantarini L, Sestini P, Frediani B, Bargagli E.
Int Immunopharmacol. 2020 Sep;86:106748.

BARI demonstrated to be a safe immune modulator that reduces the concentrations biomarkers of lung fibrosis and inflammation in RA patients, including a subgroup with interstitial lung involvement. Professor Alessandro and colleagues analysed the effects of baricitinib in a population of RA and RA-ILD patients in a real-life setting, describing any changes in lung function parameters, serum inflammatory biomarkers and fibrotic biomarkers after 6 months of treatment. Fifteen patients were recru...

Keywords: JAK, Baricitinib, Clinical, Efficacy

Translated by: Igor Kos